Author | Mark A. Rubin, MD | OncLive

Author | Mark A. Rubin, MD


Dr. Rubin on Advantages With Whole-Exome Sequencing

April 28, 2016


Mark A. Rubin, MD, professor of Pathology and Laboratory Medicine, vice chairman for Experimental Pathology, director, Translational Research Laboratory Services, Weill Cornell Medicine and New-York Presbyterian, discusses the advantages of whole-exome sequencing and how it compares with targeted sequencing.